This IDC Survey is the fifth in the series of IDC Health Insights reports examining European life sciences organizations' digital transformation (DX) strategies and priorities across the five key dimensions of DX: leadership and culture, operations, patients and customers, work model transformation, and intelligence and insights.
This final report focuses on the "intelligence and insights" dimension of DX. The analysis is based on IDC's European Tech and Industry Pulse Survey, 2019–2020, a landmark study of IT solutions, investment priorities, and emerging technologies. The 2020 sample — which included Russia, Poland, and Czech Republic — represented more than 75% of the European economy (in terms of the GDP of 40 countries). The life sciences sample consisted of 137 respondents in 13 European countries.
"The ability to learn from multisource data and generate insights at scale is critical to enable data-driven intelligent enterprise, and it is emerging as a key competitive factor in the European life sciences industry to thrive in the new realm of COVID-19," said Nino Giguashvili, senior research analyst, IDC Health Insights Europe.
"Life sciences companies are planning to increase their investments in analytics capabilities to inform decisions and intelligently automate workflows in a broad range of business areas, with a focus on patient engagement strategies as well as sales and marketing activities to enable greater personalization of messages and distribution channels to drive profitability," said Giulia Besana, research analyst, IDC Health Insights Europe.